The company said net sales for Q4 of June 30, 2025 rose 4% to $2.0 billion. It said incremental shipments made to build retailer inventory ahead of the ERP transition contributed about 13 to 14 points of benefit to net sales, and organic sales rose 8%.

1. 01

   The company said net sales for Q4 of June 30, 2025 rose 4% to $2.0 billion. It said incremental shipments made to build retailer inventory ahead of the ERP transition contributed about 13 to 14 points of benefit to net sales, and organic sales rose 8%.

2. 02

   Clorox said diluted EPS for fiscal 2025 full year was $6.52, up 190% from $2.25 a year earlier. Adjusted EPS (non-GAAP) was $7.72, up 25% from $6.17 in the year-ago period. The company said the benefit from incremental ERP shipments was an estimated about 85 to 95 cents.

3. 03

   The company said net cash provided by operations for fiscal 2025 was $981 million, up 41% from $695 million in fiscal 2024.

4. 04

   The company said it expects fiscal 2026 net sales to decline 6% to 10% from the prior year, with diluted EPS of $5.60 to $5.95 and adjusted EPS of $5.95 to $6.30. It said this outlook includes a negative impact of about 85 to 95 cents from the reversal of the benefit from incremental ERP shipments in the prior fiscal year.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.